Breaking News
0

Synergy Pharmaceuticals Inc (SGYP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Synergy's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.361 -0.019    -5.08%
07/12 - Closed. Currency in USD ( Disclaimer )
After Hours
0.360
-0.001
-0.194%
17:56:15 - Real-time Data
Type: Equity
Market: United States
ISIN: US8716393082 
CUSIP: 871639308
  • Volume: 3,257,247
  • Bid/Ask: 0.365 / 0.400
  • Day's Range: 0.360 - 0.384
Synergy 0.361 -0.019 -5.08%

SGYP Overview

 
Information about the Synergy Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.38
Day's Range0.36 - 0.384
Revenue41.35M
Open0.367
52 wk Range0.35 - 2.8
EPS - 0.56
Volume3,257,247
Market Cap89.47M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)2,770,384
P/E RatioN/A
Beta2.19
1-Year Change - 80.8%
Shares Outstanding248,037,301
Next Earnings DateMar 25, 2019
What is your sentiment on Synergy?
or
Market is currently closed. Voting is open during market hours.

Synergy Pharmaceuticals Inc News


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Doji Star Bearish 15 Current
Hanging Man 15 Current
Dragonfly Bearish 15 Current
Harami Bearish 15 Current
Harami Cross Bearish 15 Current
Bullish Engulfing 30 Current
Bullish Hammer 1H Current
Completed Patterns
Bullish Engulfing 15 1 Dec 07, 2018 03:30PM
Downside Gap Three Methods 5H 2 Dec 06, 2018 11:00AM
Bullish Engulfing 5H 2 Dec 06, 2018 11:00AM

Synergy Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 0.361 0.365 0.400 3,257,247 -5.08% USD 07/12  
  Stuttgart 0.323 1.250 1.340 0 +3.19% EUR 07/12  
  Munich 0.329 0.000 0.000 0 0.00% EUR 07/12  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 168.49 174.49 168.30 -6.23 -3.57% 42.28M 07/12  
  Alphabet A 1,046.58 1,085.03 1,039.37 -31.50 -2.92% 2.13M 07/12  
  Facebook 137.42 140.87 136.66 -2.21 -1.58% 21.20M 07/12  
  Amazon.com 1,629.13 1,718.93 1,625.46 -70.06 -4.12% 7.58M 07/12  
  Microsoft 104.82 109.45 104.30 -4.37 -4.00% 45.04M 07/12  
  Tesla 357.97 379.49 357.65 -5.09 -1.40% 11.51M 07/12  
  Exxon Mobil 77.64 80.36 77.34 -0.75 -0.96% 16.22M 07/12  
  Bank of America 25.43 26.54 25.30 -0.85 -3.23% 107.48M 07/12  
  Goldman Sachs 179.67 186.25 179.00 -4.42 -2.40% 3.92M 07/12  
  Alibaba 153.06 158.05 151.73 -2.77 -1.78% 17.45M 07/12  

Synergy Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

313

Equity Type

ORD

Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide. The Company is engaged in the discovery, research and development efforts around analogs of uroguanylin for the treatment of GI diseases and disorders. TRULANCE is designed to replicate the function of uroguanylin. Dolcanatide is being evaluated for inflammatory bowel disease (IBD). TRULANCE is approved in the United States under the trademark name TRULANCE, for the treatment of adults with chronic idiopathic constipation (CIC). In addition, it is developing TRULANCE for the treatment of adults with irritable bowel syndrome with constipation (IBS-C). Dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SGYP Comments

Write your thoughts about Synergy Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sunny Patel
Sunny Patel Nov 08, 2018 11:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this bounce back? I hv 1000@1.45
Reply
0 0
Nilesh Patel
Nilesh Patel Nov 08, 2018 11:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I doubt it will doe now
Reply
0 0
Sunny Patel
Sunny Patel Nov 08, 2018 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this bounce back? I hv 1000@1.45
Reply
0 0
Tyler Hardy
Tyler Hardy Oct 27, 2018 6:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you would think this bounces back a little bit. I'm betting it will.
Reply
0 1
Sukhjit Singh
Sukhjit Singh Oct 27, 2018 6:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no its hard
Reply
0 0
Thierry Lebeau
Thierry Lebeau Oct 26, 2018 8:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Down 72% after market to 0.42...jump in?
Reply
1 0
Sukhjit Singh
Sukhjit Singh Oct 26, 2018 10:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it good for make investments In it
Reply
0 1
Vet La
Vet La Jun 07, 2017 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
both i guess. lol
Reply
0 0
Jonathan Jones
Jonathan Jones May 11, 2017 5:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The comment section or the drug?
Reply
2 0
Mike Jee
Mike Jee Mar 30, 2016 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At all
Reply
1 0
Mike Jee
Mike Jee Mar 07, 2016 6:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nobody uses this
Reply
1 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email